Prophylactic Effects of Agomelatine for Poststroke Depression
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 420 participants.
Also called NCT05426304
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 420 participants
- Registry
-
NCT05426304
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT05426304. Randomized; quadruple masking; primary purpose prevention. Start 2022-10-01 (anticipated); primary completion 2024-05-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prophylactic Effects of Agomelatine for Poststroke Depression
- Acronym
- PRAISED
- Condition
- Depression
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Agomelatine
- Intervention (Drug)
- Placebo Tablets
- Lead sponsor
- First Affiliated Hospital, Sun Yat-Sen University
Record details
- Record id
cardio:ct-nct05426304- Content hash
91632f240a8ee2c895cfee2634ebe0b90a7b13b0358f8b0b496ac162ce9228ca